Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
CoVigilAI is a cutting-edge solution for monitoring medical literature that leverages artificial intelligence and sophisticated data analysis to identify and manage adverse drug reactions proactively, thereby safeguarding patient well-being and adhering to regulatory standards in real time. This platform simplifies the tracking of scientific and medical literature by sourcing information from major global databases like PubMed and Embase, offering customizable search parameters that enhance the pharmacovigilance literature review process. Additionally, it systematically reviews scientific articles and publications from various local journals, ensuring comprehensive global and localized literature oversight. Utilizing advanced algorithms, the system classifies Individual Case Safety Reports (ICSRs) into three categories: valid, potential, and invalid cases, while its automated key entity recognition capability adeptly identifies essential elements such as patients, medications, adverse reactions, and relevant medical events. This holistic approach not only streamlines the monitoring process but also significantly enhances the accuracy and efficiency of drug safety assessments.
Description
PubMed® is an extensive repository featuring over 35 million citations related to biomedical literature, sourced from MEDLINE, life science journals, and various online books. Many of these citations provide links to full-text articles, which can be accessed through PubMed Central and the websites of publishers. This invaluable resource is designed to facilitate the search and retrieval of literature in the biomedical and life sciences, ultimately aiming to enhance health on both a global and individual level. Although the PubMed database does not host full-text journal articles directly, it often includes hyperlinks to such content when it is accessible from other platforms, such as the publisher's site or PubMed Central (PMC). The citations within PubMed primarily originate from fields related to biomedicine and health, as well as associated disciplines that encompass life sciences, behavioral sciences, chemical sciences, and bioengineering. A significant part of PubMed is made up of MEDLINE, which contains citations from journals that have been selectively included for its collection. Researchers and healthcare professionals frequently utilize this platform to stay informed on the latest developments and findings in medical research.
API Access
Has API
No
API Access
Has API
Yes
Integrations
AWS Marketplace
No
Bibliovigilance
No
CiteDash
No
CoVigilAI
No
Cure AI
No
Embase
Yes
Noah AI
No
PubMed
Yes
Rayyan
No
Resea.AI
No
Integrations
AWS Marketplace
Yes
Bibliovigilance
Yes
CiteDash
Yes
CoVigilAI
Yes
Cure AI
Yes
Embase
No
Noah AI
Yes
PubMed
No
Rayyan
Yes
Resea.AI
Yes
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
Free
Free Trial
No
Free Version
Yes
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
Yes
Vendor Details
Company Name
CoVigilAI
Country
India
Website
covigilai.in/
Vendor Details
Company Name
PubMed
Founded
1996
Country
United States
Website
pubmed.ncbi.nlm.nih.gov/